Common questions about Dexoject (FAQ)
Q: How quickly does Dexoject start working after an injection?
A: According to official product information, Dexoject is formulated for rapid action. It is intended to provide swift, systemic control over severe inflammatory and immune-related responses, which reflects its nature as an injectable medication that bypasses the digestive tract.
Q: What are the most common side effects people notice after getting Dexoject?
A: Official regulatory documents indicate that some commonly reported effects are changes like hyperglycemia (high blood sugar), mood changes, sleep disturbances, increased appetite, and fluid retention/weight gain. If the medication is given as a local injection, some patients may notice temporary soreness at the injection site.
Q: Does Dexoject contain any ingredients I should be worried about if I have allergies?
A: Dexoject is absolutely contraindicated, meaning it must not be used, if a person has a known hypersensitivity to the active ingredient ( Dexamethasone) or any of the inactive components (excipients) in the formulation. Patients who have specific allergies, such as to sulfites, should discuss the full ingredient list with a healthcare professional, as certain formulations may contain these components.
Q: Do you gain weight from a single Dexoject injection?
A: Regulatory documents list weight gain and fluid retention as known potential side effects of this type of medication. The likelihood and severity of weight gain are generally related to the dosage and duration of the treatment course. A single, short-term injection may carry a lower risk than prolonged use, but it remains a possible effect.
Q: Can children or teenagers receive Dexoject, or is it only for adults?
A: Dexoject is used in both adults and pediatric patients across various indications. For children, the specific dosing is calculated based on their body size or weight. Official guidance states that if a child requires prolonged therapy, they must be monitored for potential growth suppression.
Q: Why do doctors sometimes use Dexoject for non-joint-related issues?
A: The official uses of Dexoject extend well beyond joint pain because its action is systemic (body-wide). Regulatory information lists therapeutic indications for severe conditions such as allergic reactions, asthma, certain types of eye disorders, blood or kidney disorders, cerebral edema, and as part of antiemetic regimens for chemotherapy.
Q: What are some less common but serious side effects to look out for with Dexoject?
A: Official information documents several serious adverse reactions. These include Secondary Adrenocortical Insufficiency (where the adrenal glands stop producing enough hormones), peptic ulceration with risk of bleeding or perforation, osteoporosis, and increased susceptibility to infections.
Q: Will Dexoject help with nerve pain, or is it better for inflammation?
A: The official mechanism of action for Dexoject is centered on its potent anti-inflammatory and immunosuppressive effects. While its use is studied in combination with local anesthetics for certain nerve blocks, its primary regulatory purpose is to control severe inflammation.
Q: Does having certain pre-existing conditions prevent someone from getting Dexoject?
A: Yes, Dexoject is absolutely contraindicated if a person has an active systemic fungal infection or a known allergy to the drug. Caution and monitoring are also required for conditions like diabetes, active peptic ulcers, high blood pressure, and congestive heart failure.
Q: Can Dexoject cause any mood changes or affect sleep?
A: Official regulatory documents indicate that the medication can affect the central nervous system. Known side effects include a range of mood changes such as euphoria, anxiety, depression, confusion, and mood swings. It can also cause sleep disturbances (insomnia).
Q: Is Dexoject a biologic drug or a traditional steroid medication?
A: Dexoject is formally classified as a synthetic adrenocortical steroid. It is a potent glucocorticosteroid related to natural cortisol hormones. According to regulatory classifications, it is not a biologic drug.
Q: Will Dexoject affect my immune system significantly?
A: Yes, the medication is designed to have potent immunosuppressive properties in order to treat inflammatory conditions. Because of this effect, it may mask signs of infection and increase the overall risk of infectious complications, particularly when high doses are used.
Q: Is it a common practice to use Dexoject for bursitis?
A: Yes, regulatory authorities have approved Dexoject for the local administration (injection) treatment of non-bacterial bursitis and other surrounding joint issues (periarthropathies).
Q: Why is Dexoject sometimes mixed with a local anesthetic before injection?
A: While the official information confirms Dexoject's use for local infiltration, research has studied using it as an adjuvant (aiding substance) to local anesthetics. The rationale for this co-administration, studied in research, is to potentially extend the duration of the anesthetic's pain-blocking effect.
Q: Does Dexoject help with the underlying disease or just mask the symptoms?
A: Studies and official information indicate that the drug suppresses the inflammatory cascade, and research has evaluated its potential to modify disease activity in conditions like Rheumatoid Arthritis. However, it is also noted in warnings that the medication can mask the signs of an infection.
Q: Can women who are planning pregnancy use Dexoject?
A: The parenteral form of this medicine is classified as Pregnancy Category C. Official regulatory guidance advises that it should be used only if the potential benefit justifies the potential risk to the fetus. Specific questions about use when planning pregnancy are best discussed with a healthcare professional.
Q: How should I store information about my Dexoject treatments for future reference?
A: Regulatory guidance suggests that patients receiving prolonged treatment with steroids should carry a Steroid Card or equivalent document. This document typically details the patient's treatment and is presented to any treating doctor or nurse in emergency or ongoing care situations.
Q: Will Dexoject cause my hair to thin or change my skin texture?
A: Yes, official regulatory documents list several skin-related adverse effects. These include acne, easy bruising, thinning of the skin, and changes in hair growth patterns (sometimes thinning, sometimes increased growth in other areas).
Q: What evidence is there that Dexoject is more effective than placebo for certain conditions?
A: Pivotal clinical trials conducted for regulatory approval have compared the drug's effects to a placebo. These studies primarily focused on Rheumatoid Arthritis and used standard measures like the ACR20 to evaluate the response rate, with collective findings suggesting a potential for the compound to modify disease activity.
Q: Can I take ibuprofen or naproxen for pain after the Dexoject shot?
A: Official interaction statements warn that taking Dexamethasone concurrently with Nonsteroidal Anti-inflammatory Drugs (NSAIDs) such as ibuprofen or naproxen is associated with an increased risk of gastrointestinal bleeding and ulceration.
Q: What should I avoid doing right after getting a Dexoject shot?
A: If you receive a local injection (e.g., into a joint), regulatory advice suggests avoiding repeated administration at short intervals. General regulatory notes on local administration suggest that, following a joint injection, strenuous use of the injected area should be restricted based on specific clinical instruction.